Gastric cancer

The Lancet

Volumn 374, Issue 9701, 2009, Pages 1593-1594

  Fujita, Tetsuji ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; HUMAN; LETTER; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE DISSECTION; MEDICAL DECISION MAKING; MICROSCOPY; MULTIMODALITY CANCER THERAPY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH SURGERY;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT SELECTION; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 70350587033     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61946-2     Document Type: Letter

References (5)

1. Hartgrink H.H., Jansen E., van Grieken N.C.T., and van de Velde C.J.H. Gastric cancer. Lancet 374 (2009) 477-490
2. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
3. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherpy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
4. Sakuramoto S., Sasako M., Yamaguchi T., et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357 (2007) 1810-1820
5. Smith D.D., Schwarz R.R., and Schwarz R.E. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 23 (2005) 7114-7124